ANI Pharmaceuticals Inc (ANIP): Depreciation & Amortization
$91.42M
Year ended 2025-12-31
$85.80M
Trailing 12 months to 2026-06-30
+17.1%
3-year compound annual growth
+15.4%
5-year compound annual growth
+29.5%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $91.42M | +35.0% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $67.73M | +13.3% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $59.79M | +4.9% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $56.97M | +20.6% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $47.25M | +5.9% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $44.64M | +0.1% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $44.61M | +32.2% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $33.74M | +20.8% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $27.93M | +25.0% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $22.34M | +223.8% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $6.90M | +77.9% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $3.88M | +249.4% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $1.11M | +95.8% | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | $567.0K | +282.5% | 2014-02-28, From 2012-01-01 |
| 2011-12-31 | $148.2K | -11.8% | 2013-02-28, From 2011-01-01 |
| 2010-12-31 | $168.0K | +22.4% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $137.3K | n/a | 2012-03-13, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $91.42M | +35.0% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.20M | +31.4% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.51M | +37.4% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $1.15M | +44.5% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $95.80M | -11.9% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $91.02M | +15.5% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $91.56M | +13.9% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $31.27M | +3.6% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $1.55M | -8.3% |
Compare ANIP, ARWR, MDGL, CORT side by side · Screen every company in Pharmaceutical Preparations ↗